» Articles » PMID: 27341475

An Effective New Cryopreservation Procedure for Pancreatic Islets Using Hollow Fiber Vitrification

Overview
Journal Horm Metab Res
Specialty Endocrinology
Date 2016 Jun 25
PMID 27341475
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed at establishing a new cryopreservation method for mouse pancreatic islets by vitrification using hollow fibers as a container. A unique feature of the hollow fiber vitrification (HFV) method is that this method achieves stable vitrification using a minimum volume of cryoprotectant (CPA) solution, thereby ensuring high viability of the islets. The cytotoxicity, optimum composition, and concentration of the CPAs for vitrifying islets were examined. The viability, functional-integrity of vitrified islets were evaluated in comparison with those vitrified by conventional methods. Insulin secretion was measured in vitro by a static incubation assay and the metabolic functions was tested after transplantation into Streptozotocin-induced diabetic mice. The combination of 15% dimethyl sulfoxide+15% ethylene glycol resulted in the best CPA solution for the HFV of islets. HFV showed the highest viability in comparison to 2 vitrification methods, open pulled straws and vitrification with EDT324 solution. The vitrified islets stably expressed β-cells markers NeuroD, Pancreatic and duodenal homeobox-1, and MafA. Transplantation of the vitrified islets achieved euglycemia of the host diabetic mice and response to an intraperitoneal glucose tolerance test to a similar extent as non-vitrified transplanted islets. The HFV method allows for efficient long-term cryopreservation of islets.

Citing Articles

Scaling Insulin-Producing Cells by Multiple Strategies.

Choi J, Cayabyab F, Perez H, Yoshihara E Endocrinol Metab (Seoul). 2024; 39(2):191-205.

PMID: 38572534 PMC: 11066437. DOI: 10.3803/EnM.2023.1910.


The effect of hydroxyethyl starch as a cryopreservation agent during freezing of mouse pancreatic islets.

Shin D, Park J, Lee H, Shim W, Jin L, Lee K Biochem Biophys Rep. 2024; 38:101658.

PMID: 38362049 PMC: 10867579. DOI: 10.1016/j.bbrep.2024.101658.


Manufacturing clinical-grade human induced pluripotent stem cell-derived beta cells for diabetes treatment.

Tan L, Chen J, Lim L, Teo A Cell Prolif. 2022; 55(8):e13232.

PMID: 35474596 PMC: 9357357. DOI: 10.1111/cpr.13232.


Pancreatic islet cryopreservation by vitrification achieves high viability, function, recovery and clinical scalability for transplantation.

Zhan L, Rao J, Sethia N, Slama M, Han Z, Tobolt D Nat Med. 2022; 28(4):798-808.

PMID: 35288694 PMC: 9018423. DOI: 10.1038/s41591-022-01718-1.


Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes.

Nagaya M, Hasegawa K, Uchikura A, Nakano K, Watanabe M, Umeyama K World J Diabetes. 2021; 12(4):306-330.

PMID: 33889282 PMC: 8040081. DOI: 10.4239/wjd.v12.i4.306.